White Matter in Schizophrenia Treatment Resistance

OBJECTIVE: Failure of antipsychotic medications to resolve symptoms in schizophrenia patients creates a clinical challenge that is known as “treatment resistance”. Its causes are unknown, but it is associated with an earlier age of onset and more severe cognitive deficits. This study tested the hypo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Psychiatry
Autors principals: Kochunov, Peter, Huang, Junchao, Chen, Song, Li, Yanli, Tan, Shuping, Fan, Fengmei, Feng, Wei, Wang, Yunhui, Rowland, Laura M., Savransky, Anya, Du, Xiaoming, Chiappelli, Joshua, Chen, Shuo, Jahanshad, Neda, Thompson, Paul M., Ryan, Meghann C., Adhikari, Bhim, Sampath, Hemalatha, Cui, Yimin, Wang, Zhiren, Yang, Fude, Tan, Yunlong, Hong, L. Elliot
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6773514/
https://ncbi.nlm.nih.gov/pubmed/31352812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2019.18101212
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars